The Six-minute Stepper Test as an Outcome Measure of Exercise Tolerance During Pulmonary Rehabilitation in With Chronic Obstructive Pulmonary Disease (COPD) Patients(STEPPER)?


The aim of this study is to show if the six-minute stepper test (ST6) is a sensible marker of exercise tolerance evolution during a pulmonary rehabilitation program in people with all stages of severity of Chronic Obstructive Pulmonary Disease (COPD).

Full Title of Study: “The Six-minute Stepper Test : Marker of Exercise Tolerance’s Evolution During Pulmonary Rehabilitation in Patients With COPD ?”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: August 2013

Detailed Description

Currently, the reference test in assessing functional capacity in COPD patients during pulmonary rehabilitation is the six-Minute Walking Test (6MWT). However, the realization of the 6MWT requires a 30m-long corridor, according to the American Thoracic Society Guidelines. Lack of sufficient space can prevent the realization of 6MWT, especially for private practitioner pulmonologists, and also in hospitals. The six-minute stepper test (ST6) which can be performed in a normal room, should be an interesting alternative.


  • Procedure: Pulmonary rehabilitation assessed with six-minute walk test and six-minute stepper test

Arms, Groups and Cohorts

  • Experimental: The six minute Stepper Test
    • Experimental : The six minute Stepper Test with a Conventional respiratory rehabilitation

Clinical Trial Outcome Measures

Primary Measures

  • The number of steps to The Six-minute Stepper Test (ST6)
    • Time Frame: 21 days
    • Assess the difference in the number of steps in ST6 before and after pulmonary rehabilitation

Participating in This Clinical Trial

Inclusion Criteria

  • Patient with COPD wtih all stages of severity
  • Hospitalized in the pulmonary rehabilitation unit in the hospital of Morlaix, with a 3 weeks pulmonary rehabilitation course

Exclusion Criteria

  • Pneumonectomy, Lobectomy less than 6 months
  • orthopedic problem
  • Balance disorder
  • Weight > 110kg

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Brest
  • Collaborator
    • Ministry of Health, France
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • FRANCIS COUTURAUD, MD,PHD, Principal Investigator, Brest University Hospital Brest,, Brittany, France 29200
    • CATHERINE LE BER-MOY, DR., Principal Investigator, Hospital of Morlaix Morlaix, Brittany, France 29600
    • CHANTAL LOCHON, DR., Principal Investigator, Hospital of Morlaix Morlaix, Brittany, France 29600

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.